ADR Biomedical Holdings Inc. (TYO:3750)
Japan · Delayed Price · Currency is JPY 785.00
+10.00 (1.29%)
Aug 27, 2026, 2:38 PM JST
ADR Biomedical Holdings Balance Sheet
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Assets
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 67 | 125 | 255 | 1,038 | 1,123 | 851 |
Cash & Short-Term Investments | 67 | 125 | 255 | 1,038 | 1,123 | 851 |
Cash Growth | -81.84% | -50.98% | -75.43% | -7.57% | 31.96% | -20.39% |
Accounts Receivable | -125 | -126 | 2 | 58 | 113 | 117 |
Other Receivables | 186 | 181 | - | - | - | - |
Receivables | 61 | 55 | 2 | 58 | 113 | 117 |
Inventory | 62 | 66 | 44 | 103 | 116 | 1,646 |
Prepaid Expenses | 108 | 78 | - | - | - | - |
Other Current Assets | 47 | 26 | 216 | 228 | 36 | 415 |
Total Current Assets | 345 | 350 | 517 | 1,427 | 1,388 | 3,029 |
Property, Plant & Equipment | - | - | 2,960 | 4,217 | 11,727 | 12,041 |
Long-Term Investments | 17 | 17 | 58 | 149 | 130 | 194 |
Goodwill | - | - | - | - | 647 | 693 |
Other Intangible Assets | - | - | 2 | 21 | 41 | 49 |
Long-Term Deferred Tax Assets | - | - | - | - | 157 | - |
Other Long-Term Assets | 1 | 1 | - | 2 | 1 | - |
Total Assets | 363 | 368 | 3,537 | 5,816 | 14,091 | 16,006 |
Liabilities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | 1 | 1 | - | - | - | - |
Accrued Expenses | - | 24 | - | - | - | - |
Short-Term Debt | 250 | - | 300 | 70 | 500 | 164 |
Current Portion of Long-Term Debt | - | - | 54 | 54 | 401 | 553 |
Current Income Taxes Payable | - | 165 | - | - | - | - |
Other Current Liabilities | 64 | 36 | 137 | 412 | 272 | 278 |
Total Current Liabilities | 315 | 226 | 491 | 536 | 1,173 | 995 |
Long-Term Debt | - | - | 2,293 | 2,347 | 7,605 | 8,550 |
Pension & Post-Retirement Benefits | 12 | 11 | - | - | - | - |
Long-Term Deferred Tax Liabilities | 107 | 107 | 110 | 125 | 1,436 | 1,517 |
Other Long-Term Liabilities | - | 2 | 13 | 14 | 1,221 | 1,229 |
Total Liabilities | 434 | 346 | 2,907 | 3,022 | 11,435 | 12,291 |
Shareholders' Equity
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | 100 | 100 | 100 | 100 | 100 | 100 |
Additional Paid-In Capital | 2,939 | 2,939 | 2,939 | 2,939 | 2,939 | 2,939 |
Retained Earnings | -3,109 | -3,015 | -2,618 | -458 | -596 | 462 |
Treasury Stock | -1 | -1 | -1 | -1 | -1 | - |
Comprehensive Income & Other | - | -1 | 210 | 210 | 210 | 211 |
Total Common Equity | -71 | 22 | 630 | 2,790 | 2,652 | 3,712 |
Minority Interest | - | - | - | 4 | 4 | 3 |
Shareholders' Equity | -71 | 22 | 630 | 2,794 | 2,656 | 3,715 |
Total Liabilities & Equity | 363 | 368 | 3,537 | 5,816 | 14,091 | 16,006 |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | 250 | - | 2,647 | 2,471 | 8,506 | 9,267 |
Net Cash (Debt) | -183 | 125 | -2,392 | -1,433 | -7,383 | -8,416 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -20.50 | 14.00 | -267.91 | -159.95 | -826.90 | -953.13 |
Filing Date Shares Outstanding | 8.93 | 8.93 | 8.93 | 8.93 | 8.93 | 8.93 |
Total Common Shares Outstanding | 8.93 | 8.93 | 8.93 | 8.93 | 8.93 | 8.93 |
Working Capital | 30 | 124 | 26 | 891 | 215 | 2,034 |
Book Value Per Share | -7.95 | 2.46 | 70.56 | 312.49 | 297.03 | 415.74 |
Tangible Book Value | -71 | 22 | 628 | 2,769 | 1,964 | 2,970 |
Tangible Book Value Per Share | -7.95 | 2.46 | 70.34 | 310.14 | 219.97 | 332.63 |